Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Under Consent Decree, J&J Delays Full Return Of Recalled OTCs Until 2012

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson pushes back to 2012 the target for returning its full slate of recalled OTC drugs to market as it adjusts to operating under a consent decree with FDA and the Department of Justice.

You may also be interested in...



J&J Promotes Preventive Care, Wellness In US Health Debate

OTC makers' stakes include loosening rules on paying for consumer products with pre-tax savings and encouragement of self-care to maintain wellness.

J&J Promotes Preventive Care, Wellness In US Health Debate

OTC makers' stakes include loosening rules on paying for consumer products with pre-tax savings and encouragement of self-care to maintain wellness.

J&J Invests In Consumer Business For Long Haul, Not Quick Sale

"We believe the consumer business at J&J is an absolute integral part of our company," says CEO Alex Gorsky.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS105012

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel